Funder: Breakthrough T1D
Due Dates: November 6, 2025 (Letter of Intent, Round 1) | May 7, 2026 (Letter of Intent, Round 2)
Funding Amounts: Award size and duration determined at full proposal stage; typical Strategic Research Agreements are up to $750,000–$900,000 over 2–3 years; see call for details.
Summary: Semi-annual gateway for submitting Letters of Intent for Strategic Research Agreements aligned with Breakthrough T1D’s research strategy in type 1 diabetes.
Key Information: Submission is via LOI; only invited applicants may submit full proposals.